Owlet, Inc.
Business
Owlet is a pediatric health platform providing FDA-cleared wearable monitors and video cameras for infants, alongside a subscription service for data-driven parenting insights. The company offers Dream Sock (pulse oximetry monitor), BabySat (prescription pulse oximeter with insurance reimbursement), Dream Sight (video monitor), and Owlet360 (subscription service analyzing sleep and health trends). Products are distributed direct-to-consumer, through major U.S. retailers including Amazon and Walmart, and internationally across 30+ countries with growing healthcare provider partnerships.
Summary from 10-K filed 2026-03-09
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 106 | 78 | 54 | 69 | 76 | |
| Cost of revenues | 52 | 39 | 31 | 46 | 41 | |
| Gross profit | 54 | 39 | 23 | 23 | 35 | |
| General and administrative | 29 | 34 | 27 | 42 | 32 | |
| Sales and marketing | 18 | 16 | 14 | 38 | 37 | |
| Research and development | 14 | 10 | 10 | 28 | 21 | |
| Total operating expenses | 62 | 60 | 51 | 108 | 91 | |
| Operating loss | −8 | −20 | −29 | −85 | −56 | |
| Interest expense, net | −3 | −2 | — | — | — | |
| Common stock warrant liability adjustment | −27 | 9 | — | — | — | |
| Other income (expense), net | −1 | 75,000 | −144,000 | 79,000 | −313,000 | |
| Total other income (expense), net | −31 | 8 | −4 | 5 | −16 | |
| Loss before income tax provision | −40 | −12 | −33 | −79 | −72 | |
| Income tax provision | −28,000 | −54,000 | −10,000 | −29,000 | −31,000 | |
| Net loss and comprehensive loss | −40 | −13 | −33 | −79 | −72 | |
| Accretion on convertible preferred stock | −3 | −5 | −5 | — | — | |
| Accretion on redeemable common stock | −84,000 | −25,000 | 0 | — | — | |
| Net loss attributable to redeemable common stockholders | −1 | −245,000 | 0 | — | — | |
| Net loss attributable to common stockholders, basic | −42 | −17 | −37 | −79 | — | |
| Net loss attributable to common stockholders, diluted | −42 | −17 | −37 | −79 | — | |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | −2.31 | −1.57 | −4.53 | −9.98 | −1.13 | |
| Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares) | 18 | 11 | 8 | 8 | 63 | |
| Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares) | 18 | 11 | 8 | 8 | 63 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 35 | 20 | 17 | 11 | 95 | |
| Restricted cash | 6 | 386,000 | 0 | — | — | |
| Accounts receivable, net of allowance for credit losses of $723 and $653, respectively | 23 | 12 | 14 | 16 | 10 | |
| Inventory | 15 | 11 | 6 | 19 | 18 | |
| Prepaid expenses and other current assets | 3 | 3 | 3 | 6 | 12 | |
| Total current assets | 82 | 46 | 40 | 51 | 136 | |
| Property and equipment, net | 295,000 | 102,000 | 377,000 | 1 | 2 | |
| Right of use assets, net | 69,000 | 138,000 | 937,000 | 2 | 3 | |
| Intangible assets, net | 1 | 975,000 | 2 | 2 | 2 | |
| Other assets | 2 | 2 | 655,000 | 1 | 666,000 | |
| Total assets | 86 | 50 | 44 | 58 | 140 | |
| Accounts payable | 12 | 11 | 14 | 30 | 28 | |
| Accrued and other expenses | 19 | 16 | 15 | 20 | 32 | |
| Current portion of deferred revenues | 2 | 1 | 1 | 1 | 1 | |
| Line of credit | 7 | 6 | 9 | 5 | 0 | |
| Current portion of long-term and other debt | 4 | 1 | — | — | — | |
| Total current liabilities | 44 | 36 | 45 | 67 | 69 | |
| Long-term debt, net | 2 | 4 | 0 | 0 | 8 | |
| Common stock warrant liabilities | 3 | 25 | 28 | 724,000 | 7 | |
| Other long-term liabilities | 197,000 | 226,000 | 928,000 | 251,000 | 712,000 | |
| Total liabilities | 50 | 66 | 74 | 69 | 85 | |
| Commitments and contingencies (Note 7) | — | — | — | — | — | |
| Mezzanine equity | 16 | 13 | 8 | 0 | 0 | |
| Common Stock, Value, Issued | 3,000 | 2,000 | 1,000 | 1,000 | 11,000 | |
| Additional paid-in capital | 327 | 238 | 218 | 212 | 199 | |
| Accumulated deficit | −308 | −268 | −256 | −223 | −143 | |
| Total stockholders equity (deficit) | 19 | −30 | −38 | −11 | 55 | |
| Total liabilities, mezzanine equity, and stockholders' equity (deficit) | 86 | 50 | 44 | 58 | 140 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 521,000 | 452,000 | 842,000 | 1 | 1 | |
| Stock-based compensation | 9 | 9 | 10 | 13 | 4 | |
| Provision for credit losses | 129,000 | −193,000 | 1 | 3 | 201,000 | |
| Impairment of intangible and other assets | 46,000 | 2 | 29,000 | — | — | |
| Amortization of right of use assets | 69,000 | 929,000 | 1 | 1 | — | |
| Amortization of debt financing costs | 2 | 1 | — | — | — | |
| Accrued warrant exchange transaction costs | 41,000 | 0 | — | — | — | |
| (Gain)/loss on extinguishment of debt | 0 | 418,000 | 0 | — | — | |
| (Gain)/loss on forgiveness on interest accrued | 0 | −508,000 | — | — | — | |
| Write-off of prepaid deposit | 347,000 | 0 | — | — | — | |
| Other adjustments, net | 367,000 | 414,000 | 80,000 | 953,000 | 725,000 | |
| Accounts receivable | −11 | 2 | 965,000 | −9 | −144,000 | |
| Prepaid expenses and other assets | −1 | −30,000 | 3 | 6 | −10 | |
| Inventory | −5 | −4 | 12 | −1 | −12 | |
| Accounts payable and accrued and other expenses | 5 | 1 | −20 | −11 | 32 | |
| Lease liabilities | −100,000 | −1 | 0 | — | — | |
| Other liabilities | 0 | −769,000 | −1 | — | — | |
| Deferred revenue | 912,000 | 240,000 | −84,000 | — | — | |
| Net cash used in operating activities | −11 | −11 | −24 | −81 | −41 | |
| Purchase of property and equipment | −273,000 | −35,000 | −16,000 | −636,000 | −969,000 | |
| Purchase of intangible assets | −114,000 | −87,000 | −43,000 | −929,000 | −1 | |
| Capitalized internal-use software development costs | −556,000 | −639,000 | 0 | — | — | |
| Net cash used in investing activities | −943,000 | −761,000 | −59,000 | −2 | −2 | |
| Proceeds from issuance of preferred stock and warrants | 0 | 9 | 28 | — | — | |
| Proceeds from issuance of common stock | 32 | 11 | 0 | — | — | |
| Proceeds from short-term borrowings | 75 | 48 | 29 | 45 | 14 | |
| Payments of short-term borrowings | −75 | −52 | −26 | −40 | −21 | |
| Proceeds from long-term borrowings | 0 | 8 | 500,000 | — | — | |
| Payments of long-term borrowings | −488,000 | −5 | −4 | −6 | −1 | |
| Payments related to debt extinguishment costs | 0 | −761,000 | 0 | — | — | |
| Employee taxes paid related to the net share settlement of stock-based awards | −2 | −1 | −397,000 | — | — | |
| Proceeds related to the issuance of common stock under stock plans | 2 | 811,000 | 427,000 | — | — | |
| Debt financing costs paid | −174,000 | −930,000 | — | — | — | |
| Warrant exchange transaction costs paid | −1 | 0 | — | — | — | |
| Proceeds from exercise of common stock warrants | 2 | 0 | — | — | — | |
| Other, net | 562,000 | 363,000 | 239,000 | 618,000 | 108,000 | |
| Net cash provided by financing activities | 32 | 16 | 29 | −878,000 | 121 | |
| Net change in cash, cash equivalents, and restricted cash | 20 | 4 | 5 | −84 | 78 | |
| Cash paid for income taxes | 45,000 | 30,000 | 11,000 | — | — | |
| Cash paid for interest | 2 | 4 | 2 | — | — | |
| Issuance of common stock in connection with warrant exchange | 47 | 0 | — | — | — | |
| Purchases of property and equipment included in accounts payable | 34,000 | 0 | — | — | — | |
| Purchases of intangible assets included in accounts payable | 102,000 | 0 | — | — | — | |
| Conversion of preferred stock | 0 | 6 | 350,000 | 0 | 47 | |
| Accretion on preferred stock and redeemable common stock | 3 | 5 | 5 | — | — | |
| Issuance of common stock warrants to underwriter | 0 | −382,000 | 0 | — | — | |
| Equity issuance costs included in accounts payable and accrued liabilities | 0 | 286,000 | 450,000 | — | — | |
| Stock-based compensation for software development | 97,000 | 86,000 | 0 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Owlet, Inc.'s CIK number?
Owlet, Inc.'s SEC CIK number is 0001816708 (1816708). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Owlet, Inc.'s SEC filings?
All of Owlet, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Owlet, Inc. last report earnings?
Owlet, Inc. (OWLT) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001816708-26-000041). This is Owlet, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Owlet, Inc.'s most recent earnings 8-K?
Owlet, Inc.'s latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001816708-26-000041. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Owlet, Inc.'s latest earnings 8-K →
Look up any company's CIK number →